Urine-based Lung Cancer ELISA Reagent Kit (CE-certified Kit)

Booth No: N604

Characteristic

Our solution focuses on urine-based samples, significantly lowering testing barriers and alleviating screening-related anxiety.

For high-risk populations:
When combined with LDCT, our urine test demonstrates outstanding performance—superior to LDCT alone and even better than LDCT combined with the CEA marker. This suggests strong potential as an auxiliary diagnostic tool for high-risk individuals, providing valuable insights to clinicians and enhancing both diagnostic accuracy and decision-making efficiency.

For lower-risk populations:
The urine test offers a well-balanced overall performance. By broadening screening coverage, it enables earlier access to the benefits of regular screening while reducing early exposure to radiation risks. Its convenience also makes it suitable for use in settings with limited medical resources, for individuals requiring frequent monitoring, or for those concerned about radiation. With medical guidance, it serves as a promising non-invasive supplementary testing option.

Menu

Urine-based Lung Cancer ELISA Reagent Kit (CE-certified Kit)

Characteristic

Other Products

Products you may be interested in

Highest Rated Products